Hepatic Disease in HIV-Infected Patients

  • Author: Mark S. Sulkowski, MD (More Info)
  • Editors in Chief: Daniel R. Kuritzkes, MD; Joseph J. Eron, Jr., MD
  • Last Reviewed: 9/4/18 (What's New)

Summary

  • The American Association for the Study of Liver Diseases (Management Guidelines) and the European Association for the Study of the Liver, European Association for the Study of Diabetes, and European Association for the Study of Obesity (Management Guidelines) guidance panels provide recommendations on the treatment of NAFLD[AASLD NAFLD; EASL NAFLD]
  • Weight reduction (by diet and exercise) of at least 3% to 5% appears to be required for improvements in steatosis; greater weight reductions of 7% to 10% are necessary for improving most histopathologic NASH features, including fibrosis[AASLD NAFLD]

Action required